UBXN11 and neoplasm: In this regard, it has been recently reported how olaparib, by activating the NFκB-mediated pathway, induces a constitutive elevated expression of the GPCR adenosine A2B receptor in HG-SOC, sustaining tumour cell growth, migration and olaparib resistance [21].